Abbott's Top India Product Phensedyl Nosedives As India Faces Severe Codeine Shortage

MUMBAI - Drug maker Abbott may have leaped to the lead position in the Indian market with the much-hyped acquisition of Piramal Healthcare's formulations business, but data shows a three-fold sales decline of its lead brand, the cough syrup Phensedyl (chlorpheniramine/codeine), in the last eight months